(Q39773343)

14 September 2017

1 reference

title

Pharmacology and neurochemistry of apomorphine (English)

1 reference

14 September 2017

Pharmacology and Neurochemistry of Apomorphine (English)

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60482-2

6 April 2023

1 reference

0 references

G. Di Chiara

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A358806

6 April 2023

G. L. Gessa

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A358806

6 April 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=358806

6 April 2023

publication date

1 January 1978

1 reference

Advances in pharmacology and chemotherapy

14 September 2017

published in

1 reference

14 September 2017

volume

15

1 reference

14 September 2017

page(s)

87-160

1 reference

Mating behavior in the male rat treated with p-chlorophenylalanine methyl ester alone and in combination with pargyline

14 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

The effect of narcotic analgesics on the homovanillic acid content of rat nucleus caudatus

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

The distribution of substance P and 5-hydroxytryptamine in the central nervous system of the dog.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Evidence for dopamine receptor stimulation by apomorphine.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Receptor activity and turnover of dopamine and noradrenaline after neuroleptics

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Dopamine and noradrenaline receptor stimulation: reversal of reserpine-induced suppression of motor activity

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Comparative psychotomimetic effects of stereoisomers of amphetamine

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Behavioral effects of l-Dopa in schizophrenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Effects of clonidine and guanethidine on peripheral sympathetic nerve function in the pithed rat

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

6-Hydroxydopamine lesions of olfactory tubercles and caudate nuclei: effect on amphetamine-induced stereotyped behavior in rats

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Role of catecholamines in the anorectic effects of amphetamine in rats

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Hypotensive effects of apomorphine in anesthetized cats

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Letter: Reduction of food intake by apomorphine: a pimozide-sensitive effect.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Self-injection of apomorphine in the rat: positive reinforcement by a dopamine receptor stimulant

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Galactorrhoea: Successful Treatment with Reduction of Plasma Prolactin Levels by Brom-ergocryptine

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Evidence for a luteolytic function of prolactin in the intact cyclic rat using 2-Br-α-ergokryptine (CB 154)

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Catecholamine Inhibition of Prolactin Secretion by Isolated Rat Adenohypophyses1

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Dopamine in dendrites of substantia nigra neurons: suggestions for a role in dendritic terminals.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Effect of perphenazine on the secretion of prolactin in vivo and in vitro.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Synthesis and pharmacology of centrally acting dopamine derivatives and analogs in relation to Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Area postrema: Chemoreceptor trigger zone for vomiting - is that all?

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Morphology of emetic chemoreceptor trigger zone in cat medulla oblongata.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Stimulation of Human-Growth-Hormone Secretion by L-Dopa

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Subcortical mechanisms in emotional behavior: affective changes following septal forebrain lesions in the albino rat.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Apomorphine in dystonia musculorum deformans

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Apomorphine in Parkinsonian tremor

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Junctions between intimately apposed cell membranes in the vertebrate brain

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

A re-evaluation of the cellular morphology of the area postrema in view of recent evidence for a chemoreceptor function.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

The Chemoreceptor Trigger Zone for Emesis in the Monkey

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Effects of apomorphine on self-stimulation behavior

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Stimulation by dopamine of adenylate cyclase in retinal homogenates and of adenosine-3':5'-cyclic monophosphate formation in intact retina

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Influence of neuroleptic drugs and apomorphine on dopamine-sensitive adenylate cyclase of retina

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Effect of Apomorphine on Growth Hormone Release in Humans1

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Regional distribution of substance P in the brain of the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Apomorphine-induced accumulation of cyclic AMP in isolated retinas of the rabbit

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

d -Amphetamine-Induced Inhibition of Central Dopaminergic Neurons: Mediation by a Striato-Nigral Feedback Pathway

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Comparison of effects of L-dopa, amphetamine and apomorphine on firing rate of rat dopaminergic neurones.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Catecholamine induced increase of cyclic adenosine 3',5'-monophosphate in rat brain in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Note on the characteristics of an apomorphine response in pigeons

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Antagonism of apomorphine by chlorinated phenothiazines

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Loss of Biological Activity of Apomorphine from Auto-Oxidation

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

SOME KINETIC AND THERMODYNAMIC CHARACTERISTICS OF APOMORPHINE DEGRADATION

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Effects of apomorphine on free-operant avoidance behavior in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Effects of apomorphine and amphetamine on schedule-controlled behavior: Reversal of tetrabenazine suppression and dopaminergic correlates

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Effects of apomorphine, (+)-amphetamine, and nialamide on tetrabenazine-induced suppression of sexual behavior in the male rat

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Treatment of parkinsonism with bromocriptine.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Changes in Plasma Growth Hormone Levels in Normal and Acromegalic Subjects Following Administration of 2-Bromo-α-Ergocryptine

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

The histochemistry of the mammalian area postrema.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Centrally acting emetics. 5. Preparation and pharmacology of 10-hydroxy-11-methoxyaporphine (Isoapocodeine). In vitro enzymic methylation of apomorphine

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Centrally acting emetics. 6. Derivatives of -naphthylamine and 2-indanamine

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

EFFECT OF CHLORPROMAZINE OR HALOPERIDOL ON FORMATION OF 3METHOXYTYRAMINE AND NORMETANEPHRINE IN MOUSE BRAIN.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Suppression by dopamine-agonists of the ethanol-induced stimulation of locomotor activity and brain dopamine synthesis.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Effects of apomorphine on exploration

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Dopaminergic nature of apomorphine-induced pecking in pigeons

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Increased release of dopane from striatal dopaminergic terminals in the rat after treatment with a neuroleptic: thioproperazine.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Development of tolerance in rats to the hypothermic effects of D-amphetamine and apomorphine.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Inhibitory Effect of Dopaminergic Stimulation on GH Release in Acromegaly

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Stable Reduction of Plasma Growth Hormone (hGH) Levels During Chronic Administration of 2-Br-α-ergocryptine (CB-154) in Acromegalic Patients

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Influence of flupenthixol and flupenthixol-decanoate on methylphenidate and apomorphine-induced compulsive gnawing in mice

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Antagonistic effects of apomorphine and haloperidol on rat striatal synaptosomal tyrosine hydroxylase.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Antagonistic effects of neuroleptics and apomorphine on synaptosomal tyrosine hydroxylase in vitro.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Dopamine-sensitive adenylate cyclase in mammalian brain: a possible site of action of antipsychotic drugs

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Effect of several dopaminergic drugs and trihexyphenidyl on cholinergic parameters in the rat striatum.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Evidence for a new type of dopamine receptor stimulating agent.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

ET495 and brain catecholamine mechanisms: evidence for stimulation of dopamine receptors.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Effect of ergot drugs on central catecholamine neurons: evidence for a stimulation of central dopamine neurons.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

1 reference

7 January 2021

Evidence for dopamine receptors in the human brain mediating sedation and sleep.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Effects of amphetamine on the turnover rate of brain catecholamines and motor activity

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

On the mode of action of apomorphine

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

The role of telencephalic dopaminergic systems in the mediation of apomorphine-stereotyped behaviour.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

The involvement of dopaminergic systems with the stereotyped behaviour patterns induced by methylphenidate.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Dopamine agonist and antagonist activities of piribedil (ET495)and its metabolites.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

The substantia nigra and stereotyped behaviour

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Differences in the nature of the stereotyped behaviour induced by aporphine derivatives in the rat and in their actions in extrapyramidal and mesolimbic brain areas

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Dyskinetic phenomena caused by the intrastriatal injection of phenylethylamine, phenylpiperazine, tetrahydroisoquinoline and tetrahydronaphthalene derivatives in the guinea pig

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Levodopa in the Treatment of Parkinsonism

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Aromatic Amino Acids and Modification of Parkinsonism

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Effects of amantadine and L-dopa on apomorphine- and d-amphetamine-induced stereotyped behaviour in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Tardive dyskinesia in patients treated with major neuroleptics: a review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Persistent Dyskinesia

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Behavioural evidence of dopamine receptor stimulation by piribedil (ET495) and its metabolite S584

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Blockage of amphetamine induced motor stimulation and stereotypy in the adult rat following neonatal treatment with 6-hydroxydopamine

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Lysergic acid diethylamide: evidence for stimulation of cerebral dopamine receptors

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

The inhibition of prolactin secretion in man by CB-154 (2-Br-alpha-ergocryptine).

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Clinical and hormonal response to bromocriptin (CB-154) in the galactorrhea syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Fine-structure of the rat's intercolumnar tubercle and its adjacent ependyma and choroid plexus, with especial reference to the appearance of its sinusoidal vessels in experimental argyria

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Comparison between the effects of apomorphine and amphetamine on operant behavior

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Some observations on pecking in pigeons

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Inhibition by apomorphine of dopamine deamination in the rat brain.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Evidence for dopamine receptors mediating sedation in the mouse brain

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Intranigral kainic acid is evidence that nigral non-dopaminergic neurones control posture

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Postsynaptic receptors are not essential for dopaminergic feedback regulation

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Haloperidol increases and apomorphine decreases striatal dopamine metabolism after destruction of striatal dopamine-sensitive adenylate cyclase by kainic acid

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Drug-induced syndromes in rats with large, chronic lesions in the corpus striatum

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Injected apomorphine and orally administered levodopa in Parkinsonism

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

The effect of dopamine and of apomorphine on dB-cAMP induced stimulation of synaptosomal tyrosine hydroxylase.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Inhibition by dopamine of 3H-noradrenaline release elicited by nerve stimulation in the isolated cat's nictitating membrane

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Relation between the action of dopamine and apomorphine and their O-methylated derivatives upon the CNS

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Mode of action of apomorphine and dexamphetamine on gnawing compulsion in rats

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Site of action of dopamine and apomorphine on compulsive gnawing behaviour in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Inhibitory role of dopamine and 5-hydroxytryptamine in the sexual behaviour of female rats

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Effects of 6-Hydroxydopamine on CNS Catecholamines, Spontaneous Motor Activity and Amphetamine Induced Hyperactivity in Rats

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Drug‐induced changes in the release of [3H]‐noradrenaline from field stimulated rat iris

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Drug-induced changes in the release of 3 H-monoamines from field stimulated rat brain slices.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

On the dopaminergic nature of the gnawing compulsion induced by apomorphine in mice

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

A note on apomorphine as a sedative

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Effects of apomorphine in vitro on the uptake and release of catecholamines in crude synaptosomal preparations of rat striatum and hypothalamus

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Neurochemical evidence for denervation supersensitivity: The effect of unilateral substantia nigra lesions on apomorphine-induced increases in neostriatal acetylcholine levels

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

The cardiovascular effects of apomorphine in the anaesthetized rat

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Influence of ergot alkaloids on pituitary prolactin and prolactin-dependent processes

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

[2-Br-alpha-ergokryptin: influence on fertility and lactation in the rat]

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Antagonism of 2-Br-α-ergokryptine-methanesulfonate (CB 154) to certain endocrine actions of centrally active drugs

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Behavioural effects in rats of morphine and amphetamine and of a combination of the two drugs

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Behavioral effects of dopamine and p-hydroxyamphetamine injected into corpus striatum of rats

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Aminergic mechanisms in corpus striatum and amphetamine-induced stereotyped behaviour

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Catecholamines and the control of prolactin secretion in humans.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Cellular localization of monoamines in the area postrema of certain mammals.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Hypothermic effect of apomorphine in the mouse

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Effects of piribedil on noradrenaline and MOPEG-SO4 levels in the rat brain.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Release of dopamine from dendrites in rat substantia nigra

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Dopaminergic hypersensitivity and cholinergic hypofunction in the pathophysiology of tardive dyskinesia

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Blockade by apomorphine of haloperidol-induced dyskinesia in schizophrenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Behavioral evidence for dopaminergic supersensitivity after chronic haloperidol

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Enhancement of apomorphine-induced inhibition of striatal dopamine-turnover following chronic haloperidol

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

The inhibition of catecholamine biosynthesis by apomorphine.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

The effect of trivastal, haloperidol and dibutyryl cyclic AMP on (14C)dopamine synthesis in rat striatum.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Influence of midbrain raphe lession on some pharmacological and biochemical effects of apomorphine in rats

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

On the role of serotonin in apomorphine-induced locomotor stimulation in rats

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Possible involvement of brain serotonin in apomorphine-induced hypothermia.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Self-inhibition by Dopaminergic Neurons

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Self-inhibition by dopaminergic neurones: disruption by (+/-)-alpha-methyl-p-tyrosine pretreatment or anterior diencephalic lesions

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Blockade of apomorphine pecking with phenothiazines

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Effects of dopaminergic receptor agonists and antagonists on the activity of the neo-striatal cholinergic system

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Apomorphine: Facilitation of sexual behaviour in female rats

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

A pimozide-sensitive effect of apomorphine on body temperature of the rabbit

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Substance P: Localization in the Central Nervous System and in Some Primary Sensory Neurons

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Die enzymatische Entstehung von Oxytyramin im Organismus und die physiologische Bedeutung der Dopadecarboxylase

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

The role of brain norepinephrine in the anorexic effects of dextroamphetamine and monoamine oxidase inhibitors in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Dopamine in the mesolimbic system of the rat brain: endogenous levels and the effects of drugs on the uptake mechanism and stimulation of adenylate cyclase activity

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Effects of 2-BR-alpha-ergokryptine (CB 154) on sex-linked rejection of pituitary isografts in female C57BL mice.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Bulbocapnine's ability to antagonize the adrenergic inhibitory action of dopamine and analogs

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Influence of chlorpromazine and promethazine on vomiting induced with apomorphine in man

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Dopamine-sensitive adenylate cyclase of the caudate nucleus of rats treated with morphine or haloperidol

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

The influence of piribedil (ET495) on components of locomotor activity

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Letter: Preliminary investigation of the metabolism of piribedil (ET 495); a new central dopaminergic agonist and potential anti-parkinson agent

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Differential effects of amphetamine, fenfluramine and norfenfluramine stereoisomers on the increase of striatum homovanillic acid in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Biochemical and behavioral antagonism between fenfluramine and apomorphine in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Effect of piribedil and one of its metabolites on the concentration of homovanillic acid in the rat brain.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

The Role of Brain Monoamines and Pineal Indoles in the Secretion of Gonadotrophins and Gonadotrophin-Releasing Factors

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Effect of Anterior Pituitary Perfusion and Intraventricular Injection of Catecholamines on FSH Release1

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Effects of 2-Br-α-ergocryptine on plasma prolactin level and milk yield in cows

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Antipsychotic drugs and dopamine-stimulated adenylate cyclase prepared from corpus striatum of rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Auto-oxidation of apomorphine

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Induction and inhibition of in vivo glucuronidation of apomorphine in mice

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Biological disposition of apomorphine. IV. Isolation and characterization of "bound" apomorphine

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Treatment of tardive dyskinesia. I. Clinical efficacy of a dopamine-depleting agent, tetrabenazine.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Treatment of tardive dyskinesia. II. Short-term efficacy of dopamine-blocking agents haloperidol and thiopropazate.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Dopamine-sensitive adenyl cyclase: possible role in synaptic transmission

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Dopamine-Sensitive Adenylate Cyclase Occurs in a Region of Substantia Nigra Containing Dopaminergic Dendrites

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Dopamine-sensitive adenylate cyclase in caudate nucleus of rat brain, and its similarity to the "dopamine receptor".

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Evidence for a receptor-mediated feedback control of striatal tyrosine hydroxylase activity.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Amphetamine and apomorphine responses in the rat following 6-OHDA lesions of the nucleus accumbens septi and corpus striatum

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Effects of Amygdaloid Lesions upon Septal Hyperemotionality in the Rat

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

The pharmacology of tardive dyskinesias

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Observations on the effect of levodopa on tardive lingual-facial-buccal dyskinesia

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Dopamine receptor site sensitivity in hyperthyroid guinea pigs: A possible model of hyperthyroid chorea

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

The influence of caffeine on d-amphetamine- and apomorphine-induced stereotyped behavior.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Centrally acting emetics. II. Norapomorphine and derivatives

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Extra-blood-brain-barrier brain structures.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Dopamine release in substantia nigra?

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Die pharmakologischen Eigenschaften des reinen Apokodeins

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

The effect of drugs acting on dopamine receptors on the body temperature of the rat

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Changes in body core and skin temperature following intracerebroventricular injection of substances in the conscious rat: interpretation of data

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Effect of psychotherapeutic drugs on hyperemotionality of rats in which the olfactory bulb was removed

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Morphine catalepsy in the rat: relation to striatal dopamine metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Cholinergic-dopaminergic interaction in the striatum: The effect of 6-hydroxydopamine or pimozide treatment on the increased striatal acetylcholine levels induced by apomorphine, piribedil andD-amphetamine

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Effects of aporphine and emetine alkaloids on central dopaminergic mechanisms in rats

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Effect of apomorphine on human-growth-hormone secretion.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Effect of apomorphine on growth hormone, prolactin, luteinizing hormone and follicle-stimulating hormone levels in human serum

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Bizarre social behaviour in rats induced by a combination of a peripheral decarboxylase inhibitor and DOPA

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Presynaptic regulation of catecholamine release

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Effects on self-stimulation behavior of drugs influencing dopaminergic neurotransmission mechanisms.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Decreased plasma growth hormone (GH) levels in acromegalics following CB 154(2-Br-alpha ergocryptine) administration

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Effects of L-dopa on serum prolactin and PIF in intact and hypophysectomized, pituitary-grafted rats.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Treatment of Non-puerperal Galactorrhoea with an Ergot Alkaloid

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Subjective and Penile Plethysmograph Responses Following Aversion-Relief and Apomorphine Aversion Therapy for Homosexual Impulses

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Subjective and Penile Plethysmograph Responses to Aversion Therapy for Homosexuality: A Follow-up Study

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Proceedings: Evidence for a dopaminergic mechanism for modulation of adrenergic transmission in the rabbit ear artery

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Synthesis and pharmacology of some 2-aminotetralins. Dopamine receptor agonists

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Evidence on the cellular localization of adenyl cyclase in the neostriatum

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Apomorphine-induced aggression in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Role of the tuberculum olfactorium in stereotyped behaviour induced by apomorphine in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Effect of morphine and chlorpromazine on apomorphine-induced stereotyped behavior.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Evidence for the methylation of apomorphine by catechol-O-methyl-transferase in vivo and in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Influence of Norepinephrine and Catecholamine-Depleting Agents on the Synthesis and Release of Prolactin and Growth Hormone1

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Prolactin and Growth Hormone Production as Influenced by Catecholamines and Agents that Affect Brain Catecholamines

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Effect of apomorphine on motility in rats

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Inhibition by Apomorphine of Prolactin Secretion in Patients with Elevated Serum Prolactin

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Drugs modifying dopaminergic activity and behaviour, the EEG and epilepsy in Papio papio

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Estrus behaviour in spayed rats after estrogen or progesterone treatment in combination with reserpine or tetrabenazine

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Stimulation of a dopamine-sensitive adenylate cyclase in homogenates of rat striatum by a metabolite of piribedil (ET 495).

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Effects of dopamine-like drugs on rat striatal adenyl cyclase have implications for CNS dopamine receptor topography.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Prevention ofl-Dopa-Induced Growth Hormone Stimulation by Hyperglycemia

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

O-methylation of apomorphine and the metabolic prolongation of apomorphine-induced stereotyped behaviour

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Inhibition of thyrotropin and prolactin secretions in primary hypothyroidism by 2-Br-alpha-ergocryptine.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

A study of the structure of the area postrema with Golgi methods.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Experimental study of the projections of the nucleus of the tractus solitarius and the area postrema in the cat.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Induction of mating behavior in rats by luteinizing hormone-releasing factor.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Letter: Cerebral phosphodiesterase and the dopamine receptor

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Selective potentiation of locomotor effects of amphetamine by midbrain raphé lesions

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Aporphines. V. Total synthesis of (plus or minus)-apomorphine

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Aporphines. 8. Total synthesis and pharmacological evaluation of (plus or minus)-apomorphine, (plus or minus)-apocodeine, (plus or minus)-N-n-propylnorapomorphine, and (plus or minus)-N-n-propylnorapocodeine

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

The apomorphine antagonism test in dogs. Experimental evidence and critical considerations on specific methodological criteria

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Effect of nigral lesion on chlorpromazine-induced acceleration of dopamine synthesis from [14C]tyrosine.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Effect of apomorphine and pimozide on synthesis and turnover of labelled catecholamines in mouse brain

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Apomorphine provoked stereotypy in the dog

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Possible role of cyclic AMP and prostaglandin E1 in the dopaminergic control of prolactin release

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Effect of drugs used in psychoses on cerebral dopamine metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Accelerated synthesis of dopamine in the rat brain after methadone

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Drug induced changes in 3H-catholamine accumulation after 3H-tyrosine.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Is There an Interaction between Dopamine and Noradrenaline Containing Neurons in the Brain?

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Further studies on the possible interaction between dopamine and noradrenaline containing neurons in the brain

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Luteinizing Hormone-Releasing Factor Potentiates Lordosis Behavior in Hypophysectomized Ovariectomized Female Rats

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Substantia nigra of the rat contains a dopamine sensitive adenylate cyclase

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Functional development of the central emetic mechanism in the puppy dog

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Letter: Stimulation of locomotor activity following injection of dopamine into the nucleus accumbens

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Ergometrine induced locomotor activity following intracerebral injection into the nucleus accumbens

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

On the dopamine-like action of apomorphine

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

On apomorphine and dopamine receptors.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Biogenic amines in the hypothalamus: effect of L-DOPA on human growth hormone levels in patients with Huntington's chorea

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Comparative effects of apomorphine, piribedil and other neurotropic agents on central analgesic-induced catatonia in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Letter: Effects of low doses of a dopamine-receptor stimulator in mania

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Is the dopamine sensitive adenylate cyclase in the rat substantia nigra coupled with 'autoreceptors'?

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Apomorphine and amphetamine stereotypy after 6-hydroxydopamine lesions of the substantia nigra

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Apomorphine: modification of its hyperthermic effect in rabbits by p-chlorophenylalanine.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Comparison of excited phases alter sedatives and tranquilizers

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Apomorphine and its dopamine-like action

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Observations on the fine structure of the substantia nigra in the cat.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Ascending catecholamine pathways and amphetamine-induced locomotor activity: Importance of dopamine and apparent non-involvement of norepinephrine

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Adenyl cyclase as an adrenergic receptor

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Effects of dopaminergic drugs and acute medial forebrain bundle lesions on striatal acetylcholine levels

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Decrease in homovanillic acid as evidence for dopamine receptor stimulation by apomorphine in the neostriatum of the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Central dopaminergic neurons: Effects of alterations in impulse flow on the accumulation of dihydroxyphenylacetic acid

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Antagonism of apomorphine-induced stereotypy and emesis in dogs by thioridazine, haloperidol, and pimozide

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Absence of serotonergic influence on apomorphine-induced stereotypy

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Synthesis and biological activity of (6aS)-10,11-dihydroxyaporphine, the optical antipode of apomorphine

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Synthesis and biological activity of some aporphine derivatives related to apomorphine

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Evidence that methadone blocks dopamine receptors in the brain

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Increase in the content of adenosine 3',5'-monophosphate in mouse forebrain during seizures and prevention of the increase by methylxanthines.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Central Effects of Anticholinergic Drugs Measured by the Apomorphine Gnawing Test in Mice

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Studies of various amphetamines, apomorphine and clonidine on body temperature and brain 5-hydroxytryptamine metabolism in rats

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Adrenergic Effect of Chronic Administration of Neuroleptics

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Altered response to apomorphine in 6-hydroxydopamine-treated rats

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Comparison of structural and stereoisomers of apomorphine on stereotyped behavior of the rat

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Effect of clonidine on cardiac acceleration in vagotomized dogs

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Norepinephrine stinulated increase of cyclic AMP levels in developing mouse brain cell cultures

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Successufl ovulation and pregnancy achieved by cb-154 (2-br-alpha-ergocryptine) in a woman with Chiari-Frommel syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Serum FSH rise induced by CB-154 (2-Br-alpha-ergocryptine) in postpartum women

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Intraspecific aggressive behavior induced by apomorphine in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Influence of isolation on the aggressive behaviour induced by apomorphine in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Influence of adrenalectomy, hypophysectomy, thyroidectomy, castration, and testosterone on apomorphine induced aggressive behaviour in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Effects of septal, amygdaloid, striatal, nigral, and olfactory lesions on apomorphine-induced intraspecific aggressive behavior in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

[Brain amines and apomorphine-induced intraspecific aggressive behavior in the rat (author's transl)]

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Effect of l-DOPA on brain acetylcholine and choline in rats

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

The role of catecholamines in the release of anterior pituitary prolactin in vitro.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Different sensitivities of the phosphodiesterases (adenosine-3',5'-cyclic phosphate 3'-phosphohydrolase) of dog cerebral cortex and erythrocytes to inhibition by synthetic agents and cold.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

FINE STRUCTURE OF THE AREA POSTREMA OF THE RABBIT BRAIN.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Effects of penfluridol and other drugs on apomorphine-induced stereotyped behavior in monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Inhibition of rat prolactin release by apomorphine in vivo and in vitro.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Conversion of apocodeine to apomorphine and norapomorphine in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

In Vitro Metabolism of Certain Nornuciferine Derivatives

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Analysis of apomorphine and norapomorphine in urine by thin-layer chromatographic fluorescence quenching

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Amphetamine psychosis: a "model" schizophrenia mediated by catecholamines.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

LSD and dopamine-sensitive adenylate-cyclase in various rat brain areas

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

A dopamine-stimulated adenylate cyclase in rat substantia nigra

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Localization of Nigral Dopamine-Sensitive Adenylate Cyclase on Neurons Originating from the Corpus Striatum

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Treatment of Sydenham's chorea with a combination of l-Dopa and a peripheral Dopa decarboxylase inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

An analysis of methylphenidate induced gnawing in guinea pigs

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Enhanced striatal acetylcholine release by chlorpromazine and its reversal by apomorphine.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Influence of ?-receptor stimulants on noradrenaline release

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Inhibition of adrenergic neurotransmission by clonidine: an action on prejunctional -receptors.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Effects of apomorphine on self-stimulation.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Catecholamine receptor agonists: effects on motor activity and rate of tyrosine hydroxylation in mouse brain

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Possible stimulatory role of brain dopamine in the copulatory behavior of male rats

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Aphrodisiac effect ofl-DOPA and apomorphine in male sexually sluggish rats

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Suppression of prolactin release by a purified porcine PIF preparation and catecholamines infused into a rat hypophysial portal vessel.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

The mechanism of antagonism between apomorphine and metoclopramide on unit discharges from nuclear structures in the brainstem of the cat.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Pharmacologically Induced Behavioural Supersensitivity to Apomorphine

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Behavioural supersensitivity to apomorphine following chronic treatment with drugs which interfere with the synaptic function of catecholamines.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Amphetamine: Differentiation by d and l Isomers of Behavior Involving Brain Norepinephrine or Dopamine

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Amphetamine- and apomorphine-induced alteration of the behavior of rats submitted to a competitive situation in a straight runway

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

A comparison of effects of apomorphine and ET495 on locomotor activity and circling behaviour in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Apomorphine in Huntington's chorea: clinical observations and theoretical considerations

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Involvement of brain cholinergic mechanisms in the action of chlorpromazine

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Inhibition of Prolactin Secretion and Successful Therapy of the Forbes-Albright Syndrome withl-Dopa*

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Postsynaptic supersensitivity after 6-hydroxy-dopamine induced degeneration of the nigro-striatal dopamine system.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Adipsia and Aphagia after 6-Hydroxydopamine Induced Degeneration of the Nigro-striatal Dopamine System

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Direct chemical stimulation of dopaminergic mechanisms in the neostriatum of the rat

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

New method for assaying antiapomorphine activity in pigeons

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Spectrofluorometric Assay of Apomorphine in Brain Tissue

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

The effect of blocking dopamine release on synthesis rate of dopamine in the striatum of the rat

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Suppression of Puerperal Lactation with an Ergot Alkaloid: A Double-blind Study

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Treatment of galactorrhea-amenorrhea syndrome with Br-ergocryptine (CB 154): Restoration of ovulatory function and fertility

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

The influence of single and chronic morphine administration on some central effects of amphetamine and apomorphine

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Treatment of drug-induced dyskinesias

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

The concentration of sympathin in different parts of the central nervous system under normal conditions and after the administration of drugs

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Turning behavior of mice with unilateral 6-hydroxydopamine lesions in the striatum: effects of apomorphine, L-DOPA, amanthadine, amphetamine and other psychomotor stimulants.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

The induction and antagonism of central nervous system stimulant-induced stereotyped behavior in the cat

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Intracranial self-stimulation in rats as a function of various stimulus parameters. 3. Influence of apomorphine on medial forebrain bundle stimulation with monopolar electrodes

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

The role of presynaptic receptors in the release and synthesis of 3H-dopamine by slices of rat striatum

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Attenuation of Postganglionic Sympathetic Nerve Activity by L-Dopa

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Reactions to apomorphine and spiroperidol of rats with striatal lesions: The relevance of kind and size of the lesion

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Dopamine receptors: a review

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

The effect of dopamine and other compounds on the activity of neurones ofHelix aspersa; Structure-activity relationships

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

The effect of beta-phenethylamine on noradrenaline and dopamine turnover in rat brain.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Supersensitivity of caudate neurones after repeated administration of haloperidol

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Release of Brain Dopamine as the Probable Mechanism for the Hypothermic Effect of D-Amphetamine

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Changes of kinetic constant of striatal tyrosine hydroxylase elicited by neuroleptics that impair the function of dopamine receptors.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Dopamine receptor binding in the corpus striatum of mammalian brain

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Brain receptors for antipsychotic drugs and dopamine: direct binding assays

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Dopamine receptors in human and calf brains, using [3H]apomorphine and an antipsychotic drug

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960482-2

7 January 2021

Biological Psychiatry

10

2

95

Angrist

1970

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60482-2

6 April 2023

33

5

193

Borison

1953

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60482-2

Journal of Pharmacology and Experimental Therapeutics

6 April 2023

38

110

86

Brand

1954

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60482-2

Journal of Pharmacology and Experimental Therapeutics

6 April 2023

39

180

591

Breese

1972

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60482-2

Journal of Pharmacology and Experimental Therapeutics

6 April 2023

53

185

560

Bunney

1973

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60482-2

6 April 2023

75

24

371

Carlsson

1972

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60482-2

European Journal of Pharmacology

6 April 2023

103

25

237

Costall

1974

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60482-2

6 April 2023

127

19

251

DeWied

1967

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60482-2

British Journal of Pharmacology

6 April 2023

129

15

285

Dhawan

1960

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60482-2

British Journal of Pharmacology

6 April 2023

130

16

137

Dhawan

1961

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60482-2

Advances in biochemical psychopharmacology

6 April 2023

133

16

477

DiChiara

1977

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60482-2

Advances in biochemical psychopharmacology

6 April 2023

138

16

571

DiChiara

1977

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60482-2

Bollettino della Societa italiana di biologia sperimentale

6 April 2023

140

24

228

Dordoni

1948

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60482-2

6 April 2023

170

52

48

Fuxe

1974

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60482-2

6 April 2023

172

52

121

Fuxe

1974

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60482-2

Journal of Pharmacology and Experimental Therapeutics

6 April 2023

173

147

409

Gaitondé

1965

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60482-2

Journal of Pharmacology and Experimental Therapeutics

6 April 2023

180

114

358

Glaviano

1955

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60482-2

6 April 2023

181

24

1

Goldberg

1972

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60482-2

Journal of Pharmacology and Experimental Therapeutics

6 April 2023

193

182

464

Groppetti

1972

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60482-2

Journal of Pharmacology and Experimental Therapeutics

6 April 2023

200

22

139

Hatcher

1923

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60482-2

6 April 2023

Molecular Pharmacology

212

12

251

Iversen

1975

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60482-2

6 April 2023

Molecular Pharmacology

228

4

367

Kakiuchi

1968

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60482-2

Journal of Pharmaceutical Sciences

6 April 2023

236

12

44

Kaul

1961

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60482-2

Journal of Pharmacology and Experimental Therapeutics

6 April 2023

246

174

94

Kier

1970

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60482-2

Journal of Pharmacology and Experimental Therapeutics

6 April 2023

256

119

406

Koster

1957

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60482-2

Journal of Pharmacology and Experimental Therapeutics

6 April 2023

278

192

336

Long

1975

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60482-2

The Comparative Pharmacology of Flupenthixol and some Reference Neuroleptics

6 April 2023

series ordinal

315

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60482-2

Journal of Pharmacology and Experimental Therapeutics

6 April 2023

318

160

40

Neff

1968

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60482-2

Journal of Pharmacology and Experimental Therapeutics

6 April 2023

325

162

294

Nybäck

1968

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60482-2

6 April 2023

396

15

256

Shaar

1973

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60482-2

6 April 2023

432

206

111

Tattersall

1971

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60482-2

Journal of Pharmacology and Experimental Therapeutics

6 April 2023

437

192

42

Thornburg

1975

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60482-2

Mode of Action of Psychomotor Stimulant Drugs

6 April 2023

series ordinal

447

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60482-2

Journal of Pharmacology and Experimental Therapeutics

6 April 2023

454

103

365

Vernier

1951

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60482-2

European Journal of Pharmacology

6 April 2023

457

36

391

VonHungen

1973

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60482-2

Journal of Pharmacology and Experimental Therapeutics

6 April 2023

459

184

542

von Voigtlander

1973

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60482-2

Journal of Pharmacology and Experimental Therapeutics

6 April 2023

461

191

82

Walters

1974

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60482-2

Journal of Pharmacology and Experimental Therapeutics

6 April 2023

464

111

329

Wang

1954

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60482-2

Journal of Pharmacology and Experimental Therapeutics

6 April 2023

468

151

339

Weissmann

1966

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60482-2

6 April 2023

470

13

313

White

1971

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60482-2

Journal of Pharmacology and Experimental Therapeutics

6 April 2023

472

177

409

Whitnack

1971

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60482-2

Journal of Pharmacology and Experimental Therapeutics

6 April 2023

476

133

332

Wilson

1961

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60482-2

Journal of Pharmacology and Experimental Therapeutics

6 April 2023

477

135

11

Wilson

1962

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60482-2

Journal of Pharmacology and Experimental Therapeutics

6 April 2023

478

111

152

Winter

1954

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60482-2

6 April 2023

Molecular Pharmacology

487

10

727

Zivkovič

1974

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60482-2

6 April 2023

Identifiers

0 references

1 reference